154 related articles for article (PubMed ID: 30636982)
1. Effects of exposure to 5-MeO-DIPT during adolescence on brain neurotransmission and neurotoxicity in adult rats.
Noworyta-Sokołowska K; Kamińska K; Rzemieniec J; Wnuk A; Wojcieszak J; Górska AM; Kreiner G; Kajta M; Gołembiowska K
Forensic Toxicol; 2019; 37(1):45-58. PubMed ID: 30636982
[TBL] [Abstract][Full Text] [Related]
2. Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats.
Noworyta-Sokołowska K; Kamińska K; Kreiner G; Rogóż Z; Gołembiowska K
Neurotox Res; 2016 Nov; 30(4):606-619. PubMed ID: 27461536
[TBL] [Abstract][Full Text] [Related]
3. Dual actions of 5-MeO-DIPT at the serotonin transporter and serotonin 5-HT
Hagino Y; Hall FS; Uhl GR; Sora I; Ikeda K
Neuropsychopharmacol Rep; 2021 Mar; 41(1):91-101. PubMed ID: 33547882
[TBL] [Abstract][Full Text] [Related]
4. Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.
Fantegrossi WE; Harrington AW; Kiessel CL; Eckler JR; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
Pharmacol Biochem Behav; 2006 Jan; 83(1):122-9. PubMed ID: 16460788
[TBL] [Abstract][Full Text] [Related]
5. The effect of repeated-intermittent exposure to 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) during adolescence on learning and memory in adult rats.
Noworyta-Sokołowska K; Górska AM; Gołembiowska K
Pharmacol Rep; 2018 Oct; 70(5):890-895. PubMed ID: 30096487
[TBL] [Abstract][Full Text] [Related]
6. 5-Methoxy-N,N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter.
Sogawa C; Sogawa N; Tagawa J; Fujino A; Ohyama K; Asanuma M; Funada M; Kitayama S
Toxicol Lett; 2007 Apr; 170(1):75-82. PubMed ID: 17382495
[TBL] [Abstract][Full Text] [Related]
7. Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission.
Herian M; Wojtas A; Sobocińska MK; Skawski M; González-Marín A; Gołembiowska K
Pharmacol Rep; 2020 Dec; 72(6):1593-1603. PubMed ID: 33174181
[TBL] [Abstract][Full Text] [Related]
8. Abuse liability profile of three substituted tryptamines.
Gatch MB; Forster MJ; Janowsky A; Eshleman AJ
J Pharmacol Exp Ther; 2011 Jul; 338(1):280-9. PubMed ID: 21474568
[TBL] [Abstract][Full Text] [Related]
9. Determination of 5-MeO-DIPT in Human Urine Using Gas Chromatography Coupled with High-Resolution Orbitrap Mass Spectrometry.
Yan X; Xiang P; Zhao Y; Yu Z; Yan H
J Anal Toxicol; 2020 Apr; 44(5):461-469. PubMed ID: 32020169
[TBL] [Abstract][Full Text] [Related]
10. Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse.
Williams MT; Herring NR; Schaefer TL; Skelton MR; Campbell NG; Lipton JW; McCrea AE; Vorhees CV
Neuropsychopharmacology; 2007 Jun; 32(6):1404-20. PubMed ID: 17047665
[TBL] [Abstract][Full Text] [Related]
11. The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT
Riga MS; Lladó-Pelfort L; Artigas F; Celada P
Neuropharmacology; 2018 Nov; 142():219-230. PubMed ID: 29221792
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Exposure to Mephedrone During Adolescence on Brain Neurotransmission and Neurotoxicity in Adult Rats.
Kamińska K; Noworyta-Sokołowska K; Górska A; Rzemieniec J; Wnuk A; Wojtas A; Kreiner G; Kajta M; Gołembiowska K
Neurotox Res; 2018 Oct; 34(3):525-537. PubMed ID: 29713996
[TBL] [Abstract][Full Text] [Related]
13. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
[TBL] [Abstract][Full Text] [Related]
14. The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.
Carbonaro TM; Eshleman AJ; Forster MJ; Cheng K; Rice KC; Gatch MB
Psychopharmacology (Berl); 2015 Jan; 232(1):275-84. PubMed ID: 24985890
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites.
Kamata T; Katagi M; Kamata HT; Miki A; Shima N; Zaitsu K; Nishikawa M; Tanaka E; Honda K; Tsuchihashi H
Drug Metab Dispos; 2006 Feb; 34(2):281-7. PubMed ID: 16280455
[TBL] [Abstract][Full Text] [Related]
16. Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes.
Narimatsu S; Yonemoto R; Saito K; Takaya K; Kumamoto T; Ishikawa T; Asanuma M; Funada M; Kiryu K; Naito S; Yoshida Y; Yamamoto S; Hanioka N
Biochem Pharmacol; 2006 Apr; 71(9):1377-85. PubMed ID: 16510126
[TBL] [Abstract][Full Text] [Related]
17. Application of hair analysis to document illegal 5-methoxy-N,N-dissopropyltrptamine (5-MeO-DiPT) use.
Wang R; Xiang P; Yu Z; Shi Y
Forensic Sci Int; 2019 Nov; 304():109972. PubMed ID: 31604205
[TBL] [Abstract][Full Text] [Related]
18. Development of an LC-MS/MS method for determining 5-MeO-DIPT in dried urine spots and application to forensic cases.
Yan X; Yuan S; Yu Z; Zhao Y; Zhang S; Wu H; Yan H; Xiang P
J Forensic Leg Med; 2020 May; 72():101963. PubMed ID: 32452453
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the developmental effects of 5-methoxy-N,N-diisopropyltryptamine (Foxy) to (+/-)-3,4-methylenedioxymethamphetamine (ecstasy) in rats.
Skelton MR; Schaefer TL; Herring NR; Grace CE; Vorhees CV; Williams MT
Psychopharmacology (Berl); 2009 Jun; 204(2):287-97. PubMed ID: 19198809
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.
Halberstadt AL
Pharmacol Biochem Behav; 2016 Apr; 143():1-10. PubMed ID: 26780349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
